A.S. Création Tapeten AG / Key word(s): Legal Matter 23.12.2014 10:30 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Following on from the search of the offices in November 2010 and the opening of administrative offence proceedings in July 2013, the French Cartel Office ("Autorité de la concurrence") has now issued a penalty notice against SCE - Société de conception et d'édition SAS ("SCE") and MCF Investissement SAS ("MCF"), two members of the A.S. Création Group. Both companies received the penalty notice on December 22, 2014. The French cartel office alleges that the companies have engaged in an information exchange in the years from 2006 and 2010 which it considers to constitute a violation of anti-trust law. The penalties issued against SCE and MCF amount to a total of EUR 5.0 million. As A.S. Création hadn't acquired the majority of the shares in the two French companies before December 2008, the former majority shareholder, the French Décoralis SA, is still jointly and severally liable for the penalties. The companies involved are currently analysing the decision and are assessing their procedural options. Irrespective of the companies' decision, an appeal against a penalty notice does not have a suspensive effect under French law, meaning that the penalties will definitely have to be paid swiftly after receipt of the request to pay. As reported earlier, Germany's Federal Cartel Office has maintained only two of its originally five allegations and these two allegations could potentially result in penalties worth EUR 10.5 million being imposed on A.S. Création and company executives (for details please refer to the ad-hoc announcements of February 25, 2014 and December 1, 2014). Now the maximum penalty amount payable in France has also been established. In respect of the risks arising from the administrative offence proceedings in Germany, A.S. Création has so far, as a precautionary measure, established a provision of EUR 2.0 million in its consolidated financial statements. Management will now examine to what extent there may be a need to establish an additional provision for the French penalties in the consolidated financial statements for the fiscal year 2014. Gummersbach, December 23, 2014 A.S. Création Tapeten AG The Managing Board Contact: Maik Krämer Director of Finance and Controlling Südstr. 47 D-51645 Gummersbach Telefon + 49 - (0)22 61/542-387 Fax + 49 - (0)22 61/542-304 E-Mail: m.kraemer@as-creation.de 23.12.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: A.S. Création Tapeten AG SüdstraÃe 47 51645 Gummersbach Germany Phone: +49 22 61 54 2-0 Fax: +49 22 61 54 2-3 04 E-mail: investor@as-creation.de Internet: http://www.as-creation.de ISIN: DE000A1TNNN5 WKN: A1TNNN Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: A.S. Création Tapeten AG: French Cartel
Top 10 Most Recent News Articles
Qonto's Banking License Raises the Stakes in Europe
A regulatory stamp can look dull on paper, yet this one changes the machinery underneath Qonto. The Paris-based finance platform has received a Credit Institution license from France's ACPR and the European Central Bank, giving it a route to offer broader lending and savings products directly to small and midsize businesses across Europe. That is a serious corporate...
Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context
Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...
Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge
Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...
Continue Reading
Navan’s Travel Survey Sells Friction as a Business Case
A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...
Continue Reading
Bank of America AML Claims Put Controls Under Fire
A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...
Continue Reading
Animal Parasite Market Growth Has a Resistance Catch
Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...
Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data
Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...
Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves
Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...
Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny
Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...
Continue Reading
BNY's December Conference Slot Merits a Careful Listen
A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...
Continue ReadingTop 5 Most Recently Viewed Articles
Wicked Cutz, Cinnabon Team Up for Bacon Jerky Debut
Ever thought you'd see the day when your protein snack could taste like a cinnamon roll? Well, folks, that day has arrived. Wicked Cutz, a force in the meat snack industry, and Cinnabon, the undisputed champs of cinnamon rolls, have rolled out a product that's bound to raise some eyebrows: bacon jerky with a sweet pastry twist. Why Bacon Jerky? You might be wondering, why...
Continue Reading
10 High-Yielding Small-Cap Stocks Under $15 in 2024
In the ever-evolving landscape of the stock market, small-cap stocks can be a gold mine for investors seeking high yields without breaking the bank. As we navigate through 2024, let's delve into a curated list of 10 small-cap stocks trading under $15 that offer attractive dividend yields. But remember, high yields can be as enticing as they are perilous, so tread with...
Continue Reading
Frazier Life Sciences Secures Over $630M for Growth Initiatives
Frazier Life Sciences (FLS) raised over $630 million back in 2024, which got everyone buzzing on the trading floor. This wasn't just pocket change; it came from an oversubscribed fundraise that saw new and existing investors jumping on board like it was Black Friday. Talk about a cash infusion! The Public Fund has amassed around $1.7 billion since its launch three years...
Continue Reading
1847 Holdings LLC Achieves Milestone with $11.1M Offering
1847 Holdings LLC Successfully Completes Public Offering 1847 Holdings LLC (NYSE American: EFSH), a company dedicated to investing in high-potential middle-market businesses, recently announced an exciting achievement. The firm has successfully closed its public offering, resulting in gross proceeds of $11.1 million. This accomplishment reflects the company's continued...
Continue Reading
Live Nation Entertainment's Stock Analysis Amid Sell-Off
Understanding Live Nation Entertainment's Recent Stock Movements The trading landscape for Live Nation Entertainment, Inc. (LYV) has seen quieter activity following a significant sell-off of 6.5%. Investors and market analysts are closely observing whether this stock will continue its downward trajectory. Technical Analysis: Support and Resistance Levels Identifying Key...
Continue Reading